聚合甲基甘丁和奥利戈(2-(2-乙) 乙氧乙基甘化暴露与妊娠期糖尿病有关吗?
Hyowon Choi1, Nam-Yun Kim2, Nalai Kim2
1Department of Prevention Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, Republic of Korea.
Toxics
|January 8, 2025
概括
暴露于加湿器消毒化学品聚乙烯瓜尼丁 (PHMG) 和化 (PGH) 的暴露与更高的妊娠糖尿病发病率有关. 这种联系甚至在考虑喘时也存在.
科学领域:
- 环境健康 环境健康
- 生殖健康 生殖健康
- 毒理学 毒理学 毒理学
背景情况:
- 含有多甲基瓜尼丁 (PHMG) 和化 (PGH) 的加湿器消毒剂引发了健康问题.
- 孕期糖尿病 (GDM) 是一种严重的妊娠并发症,对母亲和孩子的健康有潜在的长期影响.
研究的目的:
- 调查PHMG/PGH暴露与GDM发展之间的关联.
- 探索喘作为这种关系中的潜在调解者的作用.
主要方法:
- 采用了队列研究设计,确定了2003年至2017年之间的怀孕.
- 怀孕期糖尿病 (GDM) 是通过将使用PHMG/PGH的申请人的暴露数据与国家健康保险服务记录联系起来来诊断的.
- 使用后勤回归和调解分析来评估关联和潜在的介导因素,如喘.
主要成果:
- 在PHMG/PGH暴露后的怀孕中,GDM的发病率明显高 (8.9%),与暴露前 (2.4%) 相比.
- 对PHMG/PGH的暴露与GDM的几率比率增加有关 (OR 2.968).
- 建议使用剂量-反应关系,较长的暴露时间/小时与增加的GDM风险相关,独立于喘中介.
结论:
- 暴露于来自加湿器消毒剂的PHMG/PGH与妊娠糖尿病 (GDM) 的风险增加有关.
- 在PHMG/PGH暴露和GDM之间观察到的关联是独立于喘.
- 建议进行进一步的研究以验证这些发现并阐明潜在的生物机制.
相关概念视频
01:22Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
01:20Pathophysiology of Diabetes
860
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
860
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
165
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
165
01:15Hypoglycemia and Glucagon
150
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
150
01:07Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
01:27Glucose Transporters
22.4K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.4K